Sponsor Deadline:
Jul 12, 2023
Sponsor:
Pfizer Global Medical Grants
UI Contact:
Updated Date:
Jun 21, 2023
Respiratory syncytial virus (RSV) is a common respiratory virus that can cause serious illness in older adults, especially those 65 years and older. Through this RFP it is our intent to support educational programs that provide pharmacists with updates on RSV in older adults, including health equity considerations:
Project Types and Area of Interest
Program objectives may include, but are not limited to, the following:
- Describe the burden of RSV disease and clinical manifestations of RSV disease in older adults
- Discuss the mechanism of action (MOA) of RSV vaccines • Summarize the efficacy and safety data for RSV prevention options for older adults
- Understand the role pharmacists play in educating older adults about RSV prevention
- Understand the role pharmacists play in reducing health disparities in older adults, including with RSV prevention All activity types will be considered, with an emphasis on innovative programs that are designed to meet the needs of a large pharmacist audience.